It’s estimated that 90% of retail investors lose money. We help you beat those odds with concise research, education and more. Click here to see our offerings.
- A fully integrated commercial-stage specialty biopharma company targeting markets with underserved patient populations
- OSMT leverages its proprietary Osmosdex drug delivery system to manufacture tablets with optimized drug-release profiles
- Its product portfolio consists of five promoted and ~35 non-promoted products